Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Charcoal, Activated SCHEMBL30558882 | 0.97 | KDM4E (0.31) | KDM4ENPC1ALDH1A1LMNATP53 | |
| SCHEMBL14335771 | 0.87 | GABRA1 (0.31) | — | |
| SCHEMBL31229097 | 0.84 | KDM4E (0.44) | KDM4ENPC1ALDH1A1LMNATP53 | |
| SCHEMBL31413695 | 0.83 | KDM4E (0.37) | KDM4E | |
| SCHEMBL31030231 | 0.83 | CCR1 (0.32) | KDM4ELMNATP53ALOX15HTT | |
| SCHEMBL16731967 | 0.81 | ALDH1A1 (0.32) | KDM4ENPC1ALDH1A1LMNATP53 | |
| SCHEMBL2086503 | 0.79 | — | — | |
| SCHEMBL5552035 | 0.79 | NISCH (0.36) | NPC1ALDH1A1PKMRAB9A | |
| SCHEMBL17104879 | 0.79 | — | — | |
| SCHEMBL1905674 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11926079-B2 | Foam fabric | Taikone Technologies Inc. (CN) | 2024-03-12 | — | — | US | claimed |
| CN-113234095-B | Bitriazine group-containing compound and application thereof as three-dimensional electron acceptor material | 武汉工程大学 | 2022-09-27 | — | — | CN | claimed |
| CN-119751904-A | Preparation method of bio-based epoxy resin/carbon fiber composite material | 中南民族大学 | 2025-04-04 | — | — | CN | disclosed |
| CN-119118995-A | Phenyl diphenyl pyrimidine compound and organic electroluminescent device thereof | 昱镭光电科技股份有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-11926079-B2 | Foam fabric | Taikone Technologies Inc. (CN) | 2024-03-12 | — | — | US | disclosed |
| US-11926079-B2 | Foam fabric | Taikone Technologies Inc. (CN) | 2024-03-12 | — | — | US | disclosed |
| CN-114585620-B | Oxadiazole compounds or salts thereof, agrohorticultural fungicides containing the same, and methods of use thereof | 日本农药株式会社 | 2024-02-23 | — | — | CN | disclosed |
| US-20240010805-A1 | BMI RESIN FORMULATION FOR CARBON FIBER REINFORCED COMPOSITE MATERIAL, METHOD FOR MAKING IT AND BMI PREPREG | TORAY COMPOSITE MATERIALS AMERICA, INC. (US) | 2024-01-11 | — | — | US | disclosed |
| EP-4255968-A1 | BMI RESIN FORMULATION FOR CARBON FIBER REINFORCED COMPOSITE MATERIAL, METHOD FOR MAKING IT AND BMI PREPREG | Toray Composite Materials America, Inc. (US) | 2023-10-11 | — | — | EP | disclosed |
| EP-4039774-B1 | ORGANIC LIGHT-EMITTING MATERIAL AND ORGANIC LIGHT-EMITTING ELEMENT | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2023-09-20 | — | — | EP | disclosed |
| EP-3279961-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MAT CO LTD (JP) | 2023-07-19 | — | — | EP | disclosed |
| US-20030230363-A1 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON | 2003-12-18 | — | — | US | disclosed |
| EP-1363705-A1 | COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-11-26 | — | — | EP | disclosed |
| US-20030207910-A1 | Treatment of HIV and AIDS | VIIV HEALTHCARE UK (NO. 4) LIMITED (GB) | 2003-11-06 | — | — | US | disclosed |
| WO-2003068221-A1 | INDOLE, AZAINDOLE AND RELATED HETEROCYCLIC PYRROLIDINE DERIVATIVES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-08-21 | — | — | WO | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060191-A2 | NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060019-A1 | NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| US-20030069266-A1 | Aids therapy | VIIV HEALTHCARE UK (NO. 4) LIMITED (GB) | 2003-04-10 | — | — | US | disclosed |
| WO-2002062423-A1 | COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2002-08-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069266-A1 | Aids therapy | ENTPD5, CCR5, ITPA | KDM4E 1105/4885NPC1 629/4885ALDH1A1 801/4885 |
| US-20030207910-A1 | Treatment of HIV and AIDS | CD4, CCR5, IDO1 | KDM4E 1025/4885NPC1 713/4885ALDH1A1 669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.